Prevention and Management of Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Gastrointestinal Endoscopy Clinics of North America

Volumn 23, Issue 2, 2013, Pages 385-403

  Balmadrid, Bryan ^a   Kozarek, Richard ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Adverse events; Complications; Endoscopic retrograde cholangiopancreatography; ERCP; Management; Pancreatitis; Perforation; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; DICLOFENAC; GABEXATE; GLYCERYL TRINITRATE; INDOMETACIN; LOW MOLECULAR WEIGHT HEPARIN; NAFAMSTAT MESILATE; PLACEBO; PROPOFOL; SECRETIN; ULINASTATIN;

ANALGESIA; ARGON PLASMA COAGULATION; BILE DUCT RUPTURE; BLEEDING; BLOOD CLOTTING DISORDER; CEREBROVASCULAR ACCIDENT; CHOLANGITIS; CHOLECYSTITIS; CONSCIOUS SEDATION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DUODENOSCOPE; DUODENUM PERFORATION; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC THERAPY; ENDOTRACHEAL INTUBATION; ESOPHAGUS PERFORATION; GENERAL ANESTHESIA; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; JOB EXPERIENCE; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; META ANALYSIS (TOPIC); PANCREAS DIVISUM; PANCREATIC STENT; PANCREATITIS; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCLEROTHERAPY; SPHINCTEROTOMY; STENT; STOMACH PERFORATION; TREATMENT INDICATION;

BILE DUCTS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HEMORRHAGE; HUMANS; PANCREATIC DUCTS; PANCREATITIS; RISK FACTORS; SPHINCTEROTOMY, ENDOSCOPIC; STENTS;

EID: 84876487745     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2012.12.007     Document Type: Review

References (58)

1. Ginsberg G.G. Risk of colonoscopy and polypectomy. Tech Gastrointest Endosc 2008, 10:7-13.
2. Panteris V., Haringsma J., Kuipers E.J. Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy. Endoscopy 2009, 41(11):941-951.
3. Enns R., Eloubeidi M.A., Mergener K., et al. ERCP-related perforations: risk factors and management. Endoscopy 2002, 34(4):293-298.
4. Freeman M.L. Complications of endoscopic retrograde cholangiopancreatography: avoidance and management. Gastrointest Endosc Clin N Am 2012, 22(3):567-586.
5. Maple J.T., Ben-Menachem T., Anderson M.A., et al. The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc 2010, 71(1):1-9.
6. Available at:. Accessed September 15, 2012. http://www.thejag.org.uk.
7. Jowell P.S., Baillie J., Branch M.S., et al. Quantitative assessment of procedural competence. A prospective study of training in endoscopic retrograde cholangiopancreatography. Ann Intern Med 1996, 125(12):983-989.
8. Cotton P.B., Garrow D.A., Gallagher J., et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009, 70(1):80-88.
9. Moffatt D.C., Cote G.A., Avula H., et al. Risk factors for ERCP-related complications in patients with pancreas divisum: a retrospective study. Gastrointest Endosc 2011, 73(5):963-970.
10. Banerjee N., Hilden K., Baron T.H., et al. Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction. Dig Dis Sci 2011, 56(2):591-595.
11. Gong B., Hao L., Bie L., et al. Does precut technique improve selective bile duct cannulation or increase post-ERCP pancreatitis rate? A meta-analysis of randomized controlled trials. Surg Endosc 2010, 24(11):2670-2680.
12. Cennamo V., Fuccio L., Zagari R.M., et al. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. Endoscopy 2010, 42(5):381-388.
13. Testoni P.A., Giussani A., Vailati C., et al. Precut sphincterotomy, repeated cannulation and post-ERCP pancreatitis in patients with bile duct stone disease. Dig Liver Dis 2011, 43(10):792-796.
14. Mariani A., Giussani A., Di Leo M., et al. Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with the contrast injection technique in low-risk and high-risk patients. Gastrointest Endosc 2012, 75(2):339-346.
15. Cheung J., Tsoi K.K., Quan W.L., et al. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc 2009, 70(6):1211-1219.
16. Sofuni A., Maguchi H., Mukai T., et al. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Clin Gastroenterol Hepatol 2011, 9(10):851-858. [quiz: e110].
17. Cote G.A., Kumar N., Ansstas M., et al. Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc 2010, 72(4):748-754.
18. Isayama H., Komatsu Y., Tsujino T., et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 2004, 53(5):729-734.
19. Moss A.C., Morris E., Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev 2006, (2). CD004200.
20. Schmassmann A., von Gunten E., Knuchel J., et al. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 1996, 91(4):654-659.
21. Yoon W.J., Lee J.K., Lee K.H., et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc 2006, 63(7):996-1000.
22. Meister T., Heinzow H., Heinecke A., et al. Post-ERCP pancreatitis in 2364 ERCP procedures: is intraductal ultrasonography another risk factor?. Endoscopy 2011, 43(4):331-336.
23. Choudhary A., Bechtold M.L., Arif M., et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc 2011, 73(2):275-282.
24. Mazaki T., Masuda H., Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy 2010, 42(10):842-853.
25. Cote G.A., Keswani R.N., Jackson T., et al. Individual and practice differences among physicians who perform ERCP at varying frequency: a national survey. Gastrointest Endosc 2011, 74(1):65-73.e12.
26. Makela A., Kuusi T., Schroder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest 1997, 57(5):401-407.
27. Wildenhain P.M., Melhem M.F., Birsic W.I., et al. Acute hemorrhagic pancreatitis in mice: improved survival after indomethacin administration. Digestion 1989, 44(1):41-51.
28. Murray B., Carter R., Imrie C., et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003, 124(7):1786-1791.
29. Montano Loza A., Garcia Correa J., Gonzalez Ojeda A., et al. Rev Gastroenterol Mex 2006, 71(3):262-268. [in Spanish].
30. Montano Loza A., Rodriguez Lomeli X., Garcia Correa J.E., et al. Rev Esp Enferm Dig 2007, 99(6):330-336. [in Spanish].
31. Sotoudehmanesh R., Khatibian M., Kolahdoozan S., et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 2007, 102(5):978-983.
32. Elmunzer B.J., Scheiman J.M., Lehman G.A., et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012, 366(15):1414-1422.
33. Feurer M.E., Adler D.G. Post-ERCP pancreatitis: review of current preventive strategies. Curr Opin Gastroenterol 2012, 28(3):280-286.
34. Chen B., Fan T., Wang C.H. A meta-analysis for the effect of prophylactic GTN on the incidence of post-ERCP pancreatitis and on the successful rate of cannulation of bile ducts. BMC Gastroenterol 2010, 10:85.
35. Shao L.M., Chen Q.Y., Chen M.Y., et al. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci 2010, 55(1):1-7.
36. Seta T., Noguchi Y. Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis. Gastrointest Endosc 2011, 73(4):700-706.
37. Yoo Y.W., Cha S.W., Kim A., et al. The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Gut Liver 2012, 6(2):256-261.
38. Yoo K.S., Huh K.R., Kim Y.J., et al. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial. Pancreas 2011, 40(2):181-186.
39. Jowell P.S., Branch M.S., Fein S.H., et al. Intravenous synthetic secretin reduces the incidence of pancreatitis induced by endoscopic retrograde cholangiopancreatography. Pancreas 2011, 40(4):533-539.
40. Andriulli A., Leandro G., Federici T., et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007, 65(4):624-632.
41. Bai Y., Gao J., Shi X., et al. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology 2008, 8(4-5):504-509.
42. Bai Y., Gao J., Zou D.W., et al. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. Pancreas 2008, 37(3):241-246.
43. Li S., Cao G., Chen X., et al. Low-dose heparin in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2012, 24(5):477-481.
44. Pande H., Thuluvath P. Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Drugs 2003, 63(17):1799-1812.
45. Vezakis A., Fragulidis G., Nastos C., et al. Closure of a persistent sphincterotomy-related duodenal perforation by placement of a covered self-expandable metallic biliary stent. World J Gastroenterol 2011, 17(40):4539-4541.
46. Canena J., Liberato M., Horta D., et al. Short-term stenting using fully covered self-expandable metal stents for treatment of refractory biliary leaks, postsphincterotomy bleeding, and perforations. Surg Endosc 2013, 27(1):313-324.
47. Gubler C., Bauerfeind P. Endoscopic closure of iatrogenic gastrointestinal tract perforations with the over-the-scope clip. Digestion 2012, 85(4):302-307.
48. Howard T.J., Tan T., Lehman G.A., et al. Classification and management of perforations complicating endoscopic sphincterotomy. Surgery 1999, 126(4):658-663. [discussion: 664-55].
49. Anderson M.A., Fisher L., Jain R., et al. Complications of ERCP. Gastrointest Endosc 2012, 75(3):467-473.
50. Freeman M.L. Adverse outcomes of ERCP. Gastrointest Endosc 2002, 56(6 Suppl):S273-S282.
51. Tsou Y.K., Lin C.H., Liu N.J., et al. Treating delayed endoscopic sphincterotomy-induced bleeding: epinephrine injection with or without thermotherapy. World J Gastroenterol 2009, 15(38):4823-4828.
52. Shah J.N., Marson F., Binmoeller K.F. Temporary self-expandable metal stent placement for treatment of post-sphincterotomy bleeding. Gastrointest Endosc 2010, 72(6):1274-1278.
53. Itoi T., Yasuda I., Doi S., et al. Endoscopic hemostasis using covered metallic stent placement for uncontrolled post-endoscopic sphincterotomy bleeding. Endoscopy 2011, 43(4):369-372.
54. Christensen M., Matzen P., Schulze S., et al. Complications of ERCP: a prospective study. Gastrointest Endosc 2004, 60(5):721-731.
55. Andriulli A., Loperfido S., Napolitano G., et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007, 102(8):1781-1788.
56. Kapral C., Duller C., Wewalka F., et al. Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy 2008, 40(8):625-630.
57. Garewal D., Powell S., Milan S.J., et al. Sedative techniques for endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev 2012, (6). CD007274.
58. Cotton P.B., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991, 37(3):383-393.